Login / Signup

Combination of ceftaroline and daptomycin as treatment for complicated osteomyelitis.

Ana GascónMarta CastresanaNatalia Alzueta IsturizMarta MarinMaría PíoAitziber Echeverria
Published in: European journal of hospital pharmacy : science and practice (2020)
Osteomyelitis is an infection involving bone. Staphylococcus aureus is the pathogen most frequently implicated; less frequently involved are other gram-positive organisms, such as Staphylococcus epidermidis, and also gram-negative organisms. The antibiotic of choice for treatment of osteomyelitis caused by methicillin-resistant staphylococci (MRS) is vancomycin, although other alternatives such as daptomycin or teicoplanin are also considered. Osteomyelitis caused by MRS can be difficult to treat safely and effectively. This case report describes the successful use of daptomycin combined with ceftaroline for the treatment of osteomyelitis caused by methicillin-resistant S. epidermidis (MRSE) in a 54-year-old woman, emphasising the clinical pharmacist's role in antimicrobial stewardship programmes. This alternative combination has been studied in the treatment of methicillin-resistant S. aureus (MRSA), but it may also be useful in MRSE.
Keyphrases
  • staphylococcus aureus
  • methicillin resistant staphylococcus aureus
  • gram negative
  • biofilm formation
  • multidrug resistant
  • pseudomonas aeruginosa
  • soft tissue
  • postmenopausal women